Skip to main content
. 2023 Dec;143(12):2468–2475.e6. doi: 10.1016/j.jid.2023.06.191

Supplementary Table S2.

Population Variants Included in Functional Studies

Variant rs identifier Pathogenicity Predictions
Frequency1
REVEL CADD Rhapsody
p.Gln25Arg rs867378394 0.43 23.3 0.39 -
p. Glu41Gln rs771984756 0.42 24.7 0.42 0.00005
p.Asn47Ser rs28938777 0.28 22.0 0.49 0.08
p.Ala52Thr rs755465505 0.16 19.0 0.07 0.00005
p.Cys70Arg rs375718709 0.79 23.7 0.80 0.00006
p.Thr77Ile rs372880215 0.17 10.7 0.10 0.0001
p.Lys93Glu rs746109701 0.08 6.5 0.07 0.00005
p.Tyr101Phe rs769214649 0.39 18.4 0.39 0.0002
p.Glu138Lys rs750580815 0.07 11.3 0.15 0.00003
p.Gly141Asp rs758533837 0.09 0.7 0.40 0.00005
p.Ala144Thr rs780261792 0.01 2.3 0.07 0.00003
p.Ile146Val rs202059991 0.10 5.8 0.28 0.00009
p.Gln153Arg rs771496493 0.26 4.8 0.33 0.00004

The common p.Asn47Ser variant is highlighted in bold font.

Abbreviation: CADD, Combined Annotation Dependent Depletion; REVEL, Rare Exome Variant Ensemble Learner.

1

Maximum frequency observed across gnomAD (r2.1.1) populations.